G. Jakobsson

Assessment of possible nephrotoxicity from iohexol in patients with normal and impaired renal function

F. Lithner, B. Stegmayr, S. Hietala, 1998, Acta radiologica.

Targeting S100A9 Reduces Neutrophil Recruitment, Inflammation and Lung Damage in Abdominal Sepsis

H. Thorlacius, A. Schiopu, Milladur Rahman, 2021, International journal of molecular sciences.

Studying the Innate Immune Response to Myocardial Infarction in a Highly Efficient Experimental Animal Model

I. Szabó, O. Cotoi, M. Dobreanu, 2021, Romanian Journal of Cardiology.

Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation

M. Simionescu, E. Barbu, A. Schiopu, 2021, Frontiers in Immunology.

IL-2Rβγ signalling in lymphocytes promotes systemic inflammation and reduces plasma cholesterol in atherosclerotic mice.

U. Tietge, D. Engelbertsen, I. Ljungcrantz, 2021, Atherosclerosis.

S100A8/A9 is a valuable biomarker and treatment target to detect and modulate neutrophil involvement in myocardial infarction

I. Szabó, O. Cotoi, A. Szőke, 2023, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta

J. Holmberg, A. Aspberg, K. Swärd, 2023, JCI insight.

Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction

Matthew David Mulholland, H. Björkbacka, A. Rodríguez-Sinovas, 2023, Critical Care.

Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation

I. Bot, H. Björkbacka, D. Liberg, 2024, Cardiovascular research.

Short-term S100A8/A9 Blockade Promotes Cardiac Neovascularization after Myocardial Infarction.

O. Cotoi, F. Antohe, V. Șuică, 2024, Journal of cardiovascular translational research.